FDA — authorised 14 January 2005
- Application: ANDA089996
- Marketing authorisation holder: PADAGIS US
- Indication: Labeling
- Status: approved
🇺🇸 Hair-X Hair Loss Relief in United States
FDA authorised Hair-X Hair Loss Relief on 14 January 2005
Marketing authorisations
FDA
- Marketing authorisation holder: PADAGIS US
- Status: approved
Hair-X Hair Loss Relief in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Hair-X Hair Loss Relief approved in United States?
Yes. FDA authorised it on 14 January 2005; FDA has authorised it.
Who is the marketing authorisation holder for Hair-X Hair Loss Relief in United States?
PADAGIS US holds the US marketing authorisation.